Lazard Asset Management
PCVX icon

Lazard Asset Management’s Vaxcyte PCVX Stock Holding History

Lazard Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73M Sell
47,023
-17,955
-28% -$975K ﹤0.01% 765
2025
Q4 		$3M Sell
64,978
-54,114
-45% -$2.42M 0.01% 717
2025
Q3 		$4.29M Sell
119,092
-393,043
-77% -$13M 0.01% 624
2025
Q2 		$16.6M Sell
512,135
-45,659
-8% -$1.5M 0.02% 442
2025
Q1 		$21.1M Buy
557,794
+71,030
+15% +$5.68M 0.03% 338
2024
Q4 		$39.8M Buy
+486,764
New +$48.3M 0.06% 229
2023
Q3 		– Sell
-9,268
Closed -$461K – 2431
2023
Q2 		$461K Buy
+9,268
New +$439K ﹤0.01% 1143
2023
Q1 		– Sell
-7,741
Closed -$371K – 2488
2022
Q4 		$371K Buy
+7,741
New +$304K ﹤0.01% 1176

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return